Ultra-Low-Dose Rituximab in Pemphigus Vulgaris: How Low is the Lowest? [PDF]
Patel NH, Padhiyar JK.
europepmc +1 more source
Koebner's Phenomenon in Pemphigus Vulgaris. [PDF]
Mannu A, Das P, Vasudevan B, Sharma S.
europepmc +1 more source
Tofacitinib as a Novel Therapeutic Option for Pemphigus Vulgaris: A Case Report and Mechanistic Insights. [PDF]
Li X +5 more
europepmc +1 more source
Could vector-derived cadherin mimicry contribute to pemphigus vulgaris? An immunogenetic and <i>in silico</i> study involving HLA-DRB104:02 and 14:01. [PDF]
Toraman B +4 more
europepmc +1 more source
Mitochondrial-dependent apoptosis and STAT3 activation induced by oxidative stress in pemphigus vulgaris. [PDF]
Liang JP +5 more
europepmc +1 more source
Real-world outcomes with rituximab vs. conventional therapy in pemphigus vulgaris: a single-center Romanian cohort. [PDF]
Brănișteanu DE +11 more
europepmc +1 more source
Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review. [PDF]
Boonpethkaew S, Chanprapaph K.
europepmc +1 more source
Unusual Presentation of Pemphigus Vulgaris as a Solitary Ulcerative Scalp Lesion: A Case Report. [PDF]
Nejjari S +4 more
europepmc +1 more source
Severe psoriasis vulgaris complicating pemphigus vulgaris: A case report. [PDF]
Wang L, Guo G, Tang S, Sun S, Wu R.
europepmc +1 more source

